# Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

> **NCT06189183** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Thymus Neoplasms

## Interventions

- **RADIATION:** Adjuvant Hypofractionation Radiotherapy

## Key facts

- **NCT ID:** NCT06189183
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-11
- **Primary completion:** 2030-12-31
- **Final completion:** 2040-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06189183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06189183, "Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06189183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*